VITASPRING BIOMEDICAL CO., LTD. Increase (Decrease) in Accounts Payable and Accrued Liabilities
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $0 for the 3-month period ending 2023-04-30, per its 10-Q filed 2026-01-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-01-13
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2023-04-30 was $0.00.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2022-04-30 was -$1.25M, a 683979.78% decline year-over-year.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-04-30 was $183.00, a 97.89% decline year-over-year.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-01-31 was $0.00.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $1.18M, a 5.76% decline from fiscal 2022.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $1.25M.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts payable and accrued liabilities for fiscal 2021 was $0.00.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in accounts payable and accrued liabilities for fiscal 2020 was $0.00.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2023-04-30 | $0.00 10-Q · filed 2026-01-13 | |||
| 2023-01-31 | $1.18M 10-K · filed 2025-12-01 | |||
| 2022-04-30 | -$1.25M 10-Q · filed 2026-01-13 | |||
| 2022-01-31 | $1.25M 10-K · filed 2025-12-01 | |||
| 2021-07-31 | $47.00 10-Q · filed 2021-09-15 | |||
| 2021-04-30 | $183.00 10-Q · filed 2021-06-14 | $183.00 derived: sum of 2 quarters · filed 2021-06-14 | -$60.45K derived: sum of 3 quarters · filed 2021-06-14 | -$8.48K derived: sum of 4 quarters · filed 2021-06-14 |
| 2021-01-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-14 | -$60.63K derived: sum of 2 quarters · filed 2021-04-14 | -$8.66K derived: sum of 3 quarters · filed 2021-04-14 | $0.00 10-K · filed 2021-04-14 |
| 2020-10-31 | -$60.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-12-15 | -$8.66K derived: sum of 2 quarters · filed 2020-12-15 | $0.00 10-Q · filed 2020-12-15 | -$6.42K derived: sum of 4 quarters · filed 2021-06-14 |
| 2020-07-31 | $51.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-09-28 | $60.63K 10-Q · filed 2020-09-28 | $54.21K derived: sum of 3 quarters · filed 2021-06-14 | $55.62K derived: sum of 4 quarters · filed 2021-06-14 |
| 2020-04-30 | $8.66K 10-Q · filed 2021-06-14 | $2.24K derived: sum of 2 quarters · filed 2021-06-14 | $3.65K derived: sum of 3 quarters · filed 2021-06-14 | |
| 2020-01-31 | -$6.42K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-14 | -$5.01K derived: sum of 2 quarters · filed 2021-04-14 | $0.00 10-K · filed 2020-06-09 | |
| 2019-10-31 | $1.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-12-15 | $6.42K 10-Q · filed 2020-12-15 | ||
| 2019-07-31 | $5.01K 10-Q · filed 2020-09-28 | |||
| 2019-01-31 | -$1.41K 10-K · filed 2020-06-09 |